Agilent Technologies (A) had its price target lowered by Barclays PLC from $150.00 to $140.00. They now have an "overweight" rating on the stock.
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application [Yahoo! Finance]Yahoo! Finance
- Agilent Showcases Cancer Research Solutions at AACR 2026Business Wire
- How Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch [Yahoo! Finance]Yahoo! Finance
- Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents [Yahoo! Finance]Yahoo! Finance
- Infection Control Market Size Outlook 2026-2031: In-House Programs Dominate Service Delivery Mode with 53.40% Share, Reports Mordor Intelligence [TheStreet.com]TheStreet.com
A
Earnings
- 2/25/26 - Miss
A
Sec Filings
- 4/6/26 - Form 8-K/A
- 4/3/26 - Form 8-K
- 4/2/26 - Form 4
- A's page on the SEC website